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ABSTRACT 
 
Objective: Nonalcoholic fatty liver disease (NAFLD) is rapidly going to be one of the most common 
metabolic diseases which can negatively affect the liver function and needs to be more explored 
within the context of new and efficient therapies. The aim of this study was to determine the benefit 
of  Cynara cardunculus var scolymus and Cinnamomum zeylanicum mixture infusion (1.5 and 0.25 
g/100 mL and twice/day) on patients with NAFLD.  
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Methods: The study was designed as a before-after clinical trial and performed on 20 patients 
having NAFLD. They were asked to use the mixture of extracts prepared in special bags twice a 
day for 30 days. Before and after using the mixture, Liver markers of NAFLD including alanin 
aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphates (ALP), cholesterol 
(chol), triglycerides (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) and also, 
fatty liver ultrasonograhic grading were measured.  
Results: Treatment with mixture of extracts in patients with NAFLD resulted in a significant 
decrease in ALT, AST, and ALP. Also there was a significant improvement in lipid profile of the 
patients given by decreased TG, Chol, and LDL and increased HDL in serum. Moreover, a 
significant decrease in grade of sonographic examination was showed. No significant linear 
correlation was found between age, BMI and gender one way side and biochemical parameters 
and liver enzymes. 
Conclusion: Taken together, it is concluded that the mixture of Cynara cardunculus var scolymus, 
Cinnamomum zeylanicum can have beneficial effects on hepatic function and lipid profiles of 
patients with NAFLD. 
 
 
Keywords: Cinnamomum zeylanicum; Cynara cardunculus var scolymus; elevated liver enzymes; 
lipid type; nonalcoholic fatty liver disease. 
 
1. INTRODUCTION 
 
As the sedentary lifestyle has caused a high rate 
of metabolic complications like obesity and type 
2 diabetes, increasing prevalence of one related 
disorder manifested by fat deposition in the liver 
is becoming a global public health issue. Non-
alcoholic fatty liver disease (NAFLD) has been 
reported to be prevalent ranging from 9 to 36.9% 
worldwide and this percent is rising. It can lead to 
the progressive disease, non-alcoholic 
steatohepatitis (NASH), which considered the 
major cause of cirrhosis. NAFLD is very similar to 
a state in which insulin resistance occurs                  
and is mostly associated with type 2 diabetes 
and metabolic syndrome. In this way, therapeutic 
measures for insulin resistance like weight               
loss, thiazolidinediones, and metformin have 
been applicable due to their beneficial                 
effects, but specific and effective medicines for 
NAFLD are limited and a large number of 
medical investigations have focused on exploring 
new and efficient approaches for treating this 
widespread disorder [1,2,3].  
 
On the other hand, traditional medicine offers 
promising strategies for treatment of NAFLD 
given by potential history of various medicinal 
plants. There is a strong background on 
effectiveness of Cinnamomum zeylanicum in 
alleviating diabetes and metabolic syndrome via 
increased responsiveness to insulin [4,5,6,7,8]. 
Cynara cardunculus var scolymus also known as 
artichoke has been reported to reinforce hepatic 
function and lower blood cholesterol via affecting  
inhibiting the activity of the main enzyme 
involved in cholesterol biosynthesis, HMG-CoA 
reductase, in hepatocytes [9,10,11,12]. 
This study was designed to evaluate the 
protective effect of  Cynara scolymus and 
Cinnamomum zeylanicum mixture extract on 
patients with NAFLD.    
    
2. MATERIALS AND METHODS 
 
2.1 Studies 
 
This prospective cross-sectional study monitored 
20 adults aged 21-72 years (9 men and 11 
women) randomly selected patients with NAFLD 
who referred to the interdisciplinary ultrasound 
department of the clinic of Shahrekord city in the 
year 2013 for sonographic examination of the 
abdomen. They were included in this study after 
being recognized as the second stage of NAFLD 
without any history of coronary artery disease, 
diabetes, severe anemia, bleeding diathesis, 
cancer within the past "5 years", and any 
condition likely to lead to death within 5 years. 
Also, none of the patients had suffered from viral 
hepatitis or autoimmune-related disorders or 
reported alcohol consumption. The protocol of 
study was approved by Tehran University of 
Medical Science in accordance with the 
Declaration of Helsinki. In this regard all 
participants were provided with specific written 
information about the aims of the study before 
written consents were obtained. Before blood 
sampling, each individual was completely 
interviewed by a specialized physician who filled 
in a structured questionnaire about disease and 
habit diet. The included subjects were 
administered Cynara cardunculus var scolymus 
and Cinnamomum zeylanicum mixture infusion 
(1.5 and 0.25 g/100 mL respectively) for 30 days 
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at 7.5 a.m. and 2 p.m. every day. A supervisor 
carefully checked to make sure that the 
volunteers were taking infusion properly. Blood 
samples were collected from all subjects before 
using Cynara cardunculus var scolymus and 
Cinnamomum zeylanicum infusion and 12 hours 
after the last dose of 30-day treatment with 
infusion. 
 
2.2 Plant Material 
 
Cynara scolymus and Cinnamomum              
zeylanicum were supplied by Arak Medicinal 
Plants Company and identified as Cynara 
cardunculus var scolymus and Cinnamomum 
Zeylanicum in Agriculture department of Arak 
University.  
 
2.3 Infusion Preparation and Protocol 
 
Leaves of Cynara cardunculus var scolymus was 
dried and cleaned and then packed with 
cinnamon in 1.5 and 0.25 g bags. The subjects 
were instructed how to prepare the infusion by 
mixing a total of  Cynara cardunculus var 
scolymus and  Cinnamomum zeylanicum (1.5  
and  0.25  g/100  mL  and  twice/day) infusion in 
100 mL 98°C water for 30 minutes [13]. A 
qualified expert supervised the whole procedure. 
 
2.4 Biochemical Analysis of Serum 
Parameters 
 
All biochemical serum analyses including alanin  
amino  transferase  (ALT), aspartate  amino  
transferase  (AST),  alkaline  phosphates  (ALP),  
cholesterol  (Chol),  triglycerides (TG),  high-
density  lipoprotein  (HDL)  and  low-density  
lipoprotein  (LDL) were performed in the same 
laboratory. 
 
2.5 Statistical Analysis 
 
Results are presented as mean ± SD. Statistical 
analyses were conducted using SPSS software 
(version 18). The paired t- test and Wilcoxon 
Matched–Pairs Signed-Ranks Test analysis were 
applied to this study and associations between 
parameters were determined through Pearson 
correlation analysis. Value of p<0.05 were 
considered statistically significant.  
  
3. RESULTS 
 
"The mean±SD" values of subjects were for age 
(32.92±5.41) and BMI (27.59±2.81) and sex 
percentage (Male (45%), Female (55%). As 
shown in Table 1, after using Cynara 
cardunculus var scolymus and Cinnamomum 
zeylanicum infusion, the activity of ALT, AST, 
and ALP was decreased significantly. The 
combination of extracts caused not only a 
decrease in the serum LDL, TG, and Chol, but an 
increase in HDL level Table 1. Moreover, 
analysis by Wilcoxon Matched-Pairs Signed-
Ranks Test showed a significant decrease in 
grade of sonographic examination (1.84±0.76 
before and 0.95±0.71 after, p<0.001). No 
significant linear correlation was found between 
age, body mass index (BMI) and gender one way 
side and biochemical parameters and liver 
enzymes. 
 
4. DISCUSSION  
 
The present work studied the protective effects of 
mixture extract of Cynara cardunculus var 
scolymus and Cinnamomum zeylanicum on 
metabolic profile of hepatic function in related to 
lipid parameters in NAFLD patients. So, 30 days 
treatment with extract could reduce not only the 
level of serum transaminases (ALT and AST) 
and ALP, but also improved the lipid profile of 
patients given by decreased blood TG, Chol, and 
LDL and increased HDL. 
 
In a survey conducted by Clark et al. (2003), 
elevated level of serum transaminase (ALT and 
AST) was found common in the US population 
were strongly in association with obesity and 
other features of metabolic syndrome implicated 
on the existence of NAFLD. For this reason, they 
proposed that elevated serum transaminases 
could be a valid indicator or predictive of NAFLD 
if the other chronic liver diseases like alcoholic 
liver disease, viral hepatitis, and 
hemochromatosis were excluded [14]. In this 
way, monitoring the level of serum 
transaminases along with lipid parameters were 
considered as diagnostic criteria of NAFLD 
patients before and after treatment with extracts 
in this study. 
 
Lowering effect of treatment with mixture extract 
of Cynara cardunculus var scolymus and 
Cinnamomum zeylanicum on serum 
transaminases ALT and AST was significant and 
indicated  that hepatocellular damages has been 
decreased and the function of the liver cell has 
been partially improved. Furthermore, significant 
decrease in serum ALP presented beneficial 
effect of the extracts on biliary duct. 
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Table 1. The effect of aqueous extract of Cynara cardunculus var scolymus and Cinnamomum 
zeylanicum on lipid profile and liver biochemical enzymes parameters 
 
Biochemical tests Before After P value 
ALT (U/L) 46.42±12.99 35.26±14.04 0.001 
AST(U/L) 47±11.70 37.47±11.18 0.001 
ALP(IU/L) 266.84±108.07 205.05±77.97 0.000 
TG (mg/dl) 286.42±61.43 204.26±59.90 0.000 
Chol (mg/dl) 260.74±36.14 214.74±41.35 0.000 
LDL (mg/dl) 152.21±30.56 123.82±29.36 0.000 
HDL(mg/dl) 38±6.70 43.79±7.34 0.002 
 
On the other hand, observed improvement in 
lipid profile of the patients indicated that hepato-
protection of the extracts could be partially due to 
their lowering effect on the burden of liver 
function in lipid metabolism. In this regard, 
hypolipidemic effect of Cynara cardunculus var 
scolymus has become evident through both 
reduced cholesterol biosynthesis via inhibiting 
the activity of HMGCoA-reductase in hepatocytes 
and increased excretion of fecal bile acids and 
neutral sterols [9,12]. Miccadei et al. (2008) 
indicated that Cynara cardunculus var scolymus 
had a marked antioxidative potential that protects 
hepatocytes from an oxidative stress [15]. 
Another report showed that in vivo Cynara 
cardunculus var scolymus extract administration 
may be useful for the prevention of oxidative 
stress-induced hepatotoxicity [16]. Also Cynara 
cardunculus var scolymus has potent 
hepatoprotective activity [17].  Regarding our 
finding, the explanation is that beneficial effects 
of Cynara cardunculus var scolymus due to 
antioxidative potential. 
 
5. CONCLUSION 
 
In conclusion, the results of this study show that 
Cynara cardunculus var scolymus and 
Cinnamomum zeylanicum extract can be a good 
candidate for future investigations focusing on 
treatment of NAFLD.   
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